These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9378729

  • 1. CD9 antigen interacts with heparin-binding EGF-like growth factor through its heparin-binding domain.
    Sakuma T, Higashiyama S, Hosoe S, Hayashi S, Taniguchi N.
    J Biochem; 1997 Aug; 122(2):474-80. PubMed ID: 9378729
    [Abstract] [Full Text] [Related]

  • 2. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
    Nakamura K, Mitamura T, Takahashi T, Kobayashi T, Mekada E.
    J Biol Chem; 2000 Jun 16; 275(24):18284-90. PubMed ID: 10749879
    [Abstract] [Full Text] [Related]

  • 3. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
    Nakamura K, Iwamoto R, Mekada E.
    J Cell Biol; 1995 Jun 16; 129(6):1691-705. PubMed ID: 7790364
    [Abstract] [Full Text] [Related]

  • 4. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor.
    Shishido Y, Sharma KD, Higashiyama S, Klagsbrun M, Mekada E.
    J Biol Chem; 1995 Dec 08; 270(49):29578-85. PubMed ID: 7494001
    [Abstract] [Full Text] [Related]

  • 5. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
    Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E.
    J Cell Biol; 1995 Mar 08; 128(5):929-38. PubMed ID: 7876316
    [Abstract] [Full Text] [Related]

  • 6. Significance of the association between heparin-binding epidermal growth factor-like growth factor and CD9 in human gastric cancer.
    Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Isozaki K, Yamamori K, Mizuno H, Ishiguro S, Kiyohara T, Miyazaki Y, Taniguchi N, Higashiyama S, Matsuzawa Y.
    Int J Cancer; 2002 Apr 01; 98(4):505-13. PubMed ID: 11920609
    [Abstract] [Full Text] [Related]

  • 7. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viability.
    Takemura T, Hino S, Murata Y, Yanagida H, Okada M, Yoshioka K, Harris RC.
    Kidney Int; 1999 Jan 01; 55(1):71-81. PubMed ID: 9893115
    [Abstract] [Full Text] [Related]

  • 8. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
    Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K, Taniguchi N.
    J Cell Physiol; 1997 Jun 01; 171(3):291-8. PubMed ID: 9180898
    [Abstract] [Full Text] [Related]

  • 9. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
    Nishida M, Miyagawa J, Yamashita S, Higashiyama S, Nakata A, Ouchi N, Tamura R, Yamamori K, Kihara S, Taniguchi N, Matsuzawa Y.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1236-43. PubMed ID: 10807738
    [Abstract] [Full Text] [Related]

  • 10. Role of membrane-anchored heparin-binding epidermal growth factor-like growth factor and CD9 on macrophages.
    Ouchi N, Kihara S, Yamashita S, Higashiyama S, Nakagawa T, Shimomura I, Funahashi T, Kameda-Takemura K, Kawata S, Taniguchi N, Matsuzawa Y.
    Biochem J; 1997 Dec 15; 328 ( Pt 3)(Pt 3):923-8. PubMed ID: 9396739
    [Abstract] [Full Text] [Related]

  • 11. Amino-terminal processing of cell surface heparin-binding epidermal growth factor-like growth factor up-regulates its juxtacrine but not its paracrine growth factor activity.
    Nakagawa T, Higashiyama S, Mitamura T, Mekada E, Taniguchi N.
    J Biol Chem; 1996 Nov 29; 271(48):30858-63. PubMed ID: 8940069
    [Abstract] [Full Text] [Related]

  • 12. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity.
    Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E.
    EMBO J; 1994 May 15; 13(10):2322-30. PubMed ID: 8194524
    [Abstract] [Full Text] [Related]

  • 13. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
    Lagaudrière-Gesbert C, Le Naour F, Lebel-Binay S, Billard M, Lemichez E, Boquet P, Boucheix C, Conjeaud H, Rubinstein E.
    Cell Immunol; 1997 Dec 15; 182(2):105-12. PubMed ID: 9514697
    [Abstract] [Full Text] [Related]

  • 14. Latent transforming growth factor beta-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursor.
    Brooke JS, Cha JH, Eidels L.
    BMC Cell Biol; 2002 Dec 15; 3():2. PubMed ID: 11846885
    [Abstract] [Full Text] [Related]

  • 15. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis.
    Mitamura T, Umata T, Nakano F, Shishido Y, Toyoda T, Itai A, Kimura H, Mekada E.
    J Biol Chem; 1997 Oct 24; 272(43):27084-90. PubMed ID: 9341148
    [Abstract] [Full Text] [Related]

  • 16. Cell surface monkey CD9 antigen is a coreceptor that increases diphtheria toxin sensitivity and diphtheria toxin receptor affinity.
    Cha JH, Brooke JS, Ivey KN, Eidels L.
    J Biol Chem; 2000 Mar 10; 275(10):6901-7. PubMed ID: 10702250
    [Abstract] [Full Text] [Related]

  • 17. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor.
    Raab G, Kover K, Paria BC, Dey SK, Ezzell RM, Klagsbrun M.
    Development; 1996 Feb 10; 122(2):637-45. PubMed ID: 8625815
    [Abstract] [Full Text] [Related]

  • 18. Toxin binding site of the diphtheria toxin receptor: loss and gain of diphtheria toxin binding of monkey and mouse heparin-binding, epidermal growth factor-like growth factor precursors by reciprocal site-directed mutagenesis.
    Cha JH, Brooke JS, Eidels L.
    Mol Microbiol; 1998 Sep 10; 29(5):1275-84. PubMed ID: 9767594
    [Abstract] [Full Text] [Related]

  • 19. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate.
    Higashiyama S, Abraham JA, Klagsbrun M.
    J Cell Biol; 1993 Aug 10; 122(4):933-40. PubMed ID: 8349739
    [Abstract] [Full Text] [Related]

  • 20. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
    Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N.
    Mol Biol Cell; 1995 Aug 10; 6(8):967-80. PubMed ID: 7579712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.